Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-Small Cell Lung Cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Chest"
DOI: 10.1016/j.chest.2021.06.027
Abstract: BACKGROUND Targeted therapies for advanced non-small cell lung cancer (NSCLC) with oncogenic drivers have caused a paradigm shift in care. Biomarker testing is needed to assess eligibility for these therapies. Pulmonologists often perform bronchoscopy, providing… read more here.
Keywords: knowledge practice; practice; biomarker; lung cancer ... See more keywords
Use of cardiac risk biomarker testing in a naturopathic medicine teaching center: Lessons on standard of care
Sign Up to like & getrecommendations! Published in 2020 at "European Journal of Integrative Medicine"
DOI: 10.1016/j.eujim.2020.101135
Abstract: Abstract Introduction Cardiovascular disease (CVD) is the leading cause of mortality in the United States. Since atherosclerosis is an inflammatory disease, it is critical for integrative practitioners to have insight into the level of cardiovascular… read more here.
Keywords: use cardiac; medicine; risk; biomarker testing ... See more keywords
P1.01-025 Biomarker Testing in Advanced NSCLC: A Simulation-Based Assessment of Medical Oncologists
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Thoracic Oncology"
DOI: 10.1016/j.jtho.2017.09.679
Abstract: standards of care for patients with advanced non-small cell lung cancer (NSCLC), which has resulted in 5 updates to the National Comprehensive Cancer Network (NCCN) Lung Cancer Guidelines® in 2017 alone.1 As a result, oncologists… read more here.
Keywords: 025 biomarker; biomarker testing; advanced nsclc; simulation ... See more keywords
Accreditation, setting and experience as indicators to assure quality in oncology biomarker testing laboratories
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Cancer"
DOI: 10.1038/s41416-018-0204-9
Abstract: BackgroundPredictive biomarkers allow clinicians to optimise cancer treatment decisions. Therefore, molecular biomarker test results need to be accurate and swiftly available. To ensure quality of oncology biomarker testing, external quality assessments (EQA) for somatic variant… read more here.
Keywords: quality; accreditation; biomarker; biomarker testing ... See more keywords
Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study
Sign Up to like & getrecommendations! Published in 2018 at "European Respiratory Journal"
DOI: 10.1183/13993003.01467-2017
Abstract: ALK rearrangement and EGFR/KRAS mutations constitute the primary biomarkers tested to provide targeted or nontargeted therapies in advanced nonsmall cell lung cancer (NSCLC) patients. Our objective was to assess the cost-effectiveness of biomarker testing for… read more here.
Keywords: biomarker; cost effectiveness; biomarker testing; advanced nonsmall ... See more keywords
Biomarker testing patterns and trends among patients with metastatic lung cancer.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e13667
Abstract: e13667Background: Guidelines for biomarker testing of metastatic lung cancer patients aid oncologists in making targeted treatment decisions. Despite evidence demonstrating the benefits of genomic ... read more here.
Keywords: biomarker testing; metastatic lung; lung cancer;
Identifying barriers to equitable biomarker testing in underserved patients with NSCLC: A mixed-methods study to inform quality improvement opportunities.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.39.28_suppl.123
Abstract: 123 Background: Despite recent advances in cancer precision medicine, patients from underserved communities do not have equal access to biomarker testing and targeted therapies. This study used a mixed-methods approach to identify barriers to equitable… read more here.
Keywords: medicine; biomarker testing; biomarker; survey ... See more keywords
Racial disparities in comprehensive biomarker testing and clinical trial enrollment among patients with metastatic colorectal cancer (mCRC).
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.39.28_suppl.125
Abstract: 125 Background: Racial disparities may exist at many levels in the health care system; in oncology, yet little is known about racial disparities in biomarker testing and clinical trial enrollment among patients with mCRC. This… read more here.
Keywords: clinical trial; trial; biomarker testing; testing clinical ... See more keywords
Impact of race on biomarker testing among HER2- advanced breast cancer (ABC) patients (pts) in the United States: Results from a real-world study.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.10598
Abstract: 10598 Background: African Americans (AA) have the highest breast cancer (BC) mortality rate. Access to treatment is a known contributing factor. In the past 4 years, several targeted therapies for HER2- BC have become available… read more here.
Keywords: race; testing rates; cancer; white pts ... See more keywords
Empowering pathologists to lead immuno-oncology (IO) biomarker testing in the community.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2022.40.28_suppl.348
Abstract: 348 Background: As the landscape of immuno-oncology (IO) expands, there is a growing need to improve biomarker testing processes in the community. To educate and empower pathologists to lead in this area, the American Society… read more here.
Keywords: oncology; community; immuno oncology; biomarker testing ... See more keywords
Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.22.02328
Abstract: PURPOSE To provide evidence-based recommendations for practicing physicians and other health care providers on immunotherapy and biomarker testing for head and neck cancers. METHODS ASCO convened an Expert Panel of medical oncology, surgical oncology, radiation… read more here.
Keywords: evidence; oncology; biomarker testing; head neck ... See more keywords